Published in Clin Chem on April 01, 1993
Identifying cases of heroin toxicity where 6-acetylmorphine (6-AM) is not detected by toxicological analyses. Forensic Sci Med Pathol (2016) 1.39
Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend (2006) 0.98
Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal Bioanal Chem (2008) 0.90
Determining plasma morphine levels using GC-MS after solid phase extraction to monitor drug levels in the postoperative period. Clinics (Sao Paulo) (2008) 0.75
Epidemic listeriosis--evidence for transmission by food. N Engl J Med (1983) 11.72
The Morphogenesis and Significance of Degenerative Verrucal Endocardiosis (Terminal Endocarditis, Endocarditis Simplex, Nonbacterial Thrombotic Endocarditis). Am J Pathol (1944) 3.86
A Comparative Study of the Pathology of Scrub Typhus (Tsutsugamushi Disease) and Other Rickettsial Diseases. Am J Pathol (1945) 2.99
Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry (1996) 2.95
Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther (1994) 2.90
Risk of respiratory distress syndrome related to gestational age, route of delivery, and maternal diabetes. Am J Obstet Gynecol (1971) 2.81
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol (1993) 2.31
Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol (1998) 1.99
Sweat testing for heroin, cocaine, and metabolites. J Anal Toxicol (1994) 1.86
Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction (1997) 1.79
An assessment of the validity of a computer system for probabilistic record linkage of birth and infant death records in Canada. The Fetal and Infant Health Study Group. Chronic Dis Can (2000) 1.71
Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci (1990) 1.68
Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH) J Anal Toxicol (1993) 1.66
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry (1990) 1.54
The role of ecgonine methyl ester in the interpretation of cocaine concentrations in postmortem blood. J Anal Toxicol (1993) 1.51
Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am J Kidney Dis (1994) 1.50
The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos (1985) 1.49
Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J Anal Toxicol (1996) 1.47
Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes. Drug Alcohol Depend (2001) 1.46
Cocaine use early in treatment predicts outcome in a behavioral treatment program. J Consult Clin Psychol (1998) 1.46
Experimental aspects of peripheral vascular occlusion of the intestine. Surg Gynecol Obstet (1965) 1.45
Actinomycosis infections associated with intrauterine contraceptive devices. Obstet Gynecol (1975) 1.45
Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant (1993) 1.43
Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol (2001) 1.41
Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern? J Perinatol (2011) 1.40
Incidence of cannabinoids in medical examiner urine specimens. J Forensic Sci (1988) 1.39
Testing human hair for drugs of abuse. II. Identification of unique cocaine metabolites in hair of drug abusers and evaluation of decontamination procedures. J Anal Toxicol (1992) 1.39
Relation between stillbirth and specific chlorination by-products in public water supplies. Environ Health Perspect (2000) 1.35
Drug errors and incidents in a neonatal intensive care unit. A quality assurance activity. Am J Dis Child (1989) 1.32
Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl) (1998) 1.32
Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J Anal Toxicol (1995) 1.29
Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine. J Anal Toxicol (1993) 1.28
Pharmacokinetics and pharmacodynamics of intranasal "snorted" heroin. J Anal Toxicol (1993) 1.21
Subjective and physiologic effects of intravenous buprenorphine in humans. Clin Pharmacol Ther (1993) 1.19
Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry. Clin Chem (1994) 1.16
Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther (1996) 1.16
Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J Anal Toxicol (1996) 1.16
Three homologs of rds/peripherin in Xenopus laevis photoreceptors that exhibit covalent and non-covalent interactions. J Cell Sci (1996) 1.15
Retinal degeneration slow (rds) in mouse results from simple insertion of a t haplotype-specific element into protein-coding exon II. Genomics (1995) 1.12
The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug Alcohol Depend (2000) 1.12
Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther (1999) 1.08
Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium, and urine. J Pediatr (1992) 1.08
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J Anal Toxicol (2000) 1.07
Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther (1992) 1.07
Fetal biophysical profile and perinatal death. Obstet Gynecol (1987) 1.07
Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol (1994) 1.07
Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglion neurons. J Neurochem (1989) 1.06
IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am J Kidney Dis (2000) 1.06
Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing. J Anal Toxicol (1999) 1.05
Massive pericardial effusion as a cause for sudden deterioration of a very low birthweight infant. Am J Perinatol (1993) 1.05
Changes in stillbirth and infant mortality associated with increases in preterm birth among twins. Pediatrics (2001) 1.04
Novel 4'-substituted and 4',4"-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors. J Med Chem (1995) 1.03
Validity of autism diagnoses using administrative health data. Chronic Dis Can (2009) 1.03
HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives for evidence of viral exposure? N Engl J Med (1986) 1.02
Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol Biochem Behav (1990) 1.01
Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol (1995) 1.01
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction (1998) 1.01
Alcohol intoxication and serum osmolality. Lancet (1975) 1.01
Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol (1996) 1.00
Neonatal asphyxia. I. Relationship of obstetric and neonatal complications to neonatal mortality in 38,405 consecutive deliveries. J Pediatr (1980) 1.00
Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. J Pharmacol Exp Ther (1991) 1.00
Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans. Ther Drug Monit (1998) 0.99
The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther (1992) 0.98
Pathogenesis of IgA nephropathy. Ann Med Interne (Paris) (1999) 0.98
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans. Drug Metab Dispos (2000) 0.97
Implausible birth weight for gestational age. Am J Epidemiol (2001) 0.97
Subjective and physiological effects after controlled Sativex and oral THC administration. Clin Pharmacol Ther (2011) 0.97
When case management isn't enough: a model of paraprofessional advocacy for drug- and alcohol-abusing mothers. J Case Manag (1996) 0.95
Perinatal listeriosis: report of an outbreak. Pediatr Infect Dis (1985) 0.95
Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. NIDA Res Monogr (1997) 0.95
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol (2000) 0.95
Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl (1999) 0.95
Causes and consequences of recent increases in preterm birth among twins. Obstet Gynecol (2001) 0.95
Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol. J Anal Toxicol (1987) 0.93
The Matthew effect: infant mortality in Canada and internationally. Pediatrics (2000) 0.93
Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog. Drug Metab Dispos (1978) 0.93
Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings. Arch Gen Psychiatry (1988) 0.92
Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem (1994) 0.92
Development of the ICD-10 Procedure Coding System (ICD-10-PCS). J AHIMA (1998) 0.91
1,1,1-trichloroethane: report of a fatal intoxication. Clin Toxicol (1976) 0.91
Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin. J Anal Toxicol (2001) 0.90
Interpretation of low postmortem concentrations of ethanol. J Forensic Sci (1993) 0.90
Benign unexplained respiratory distress of the newborn infant. Pediatr Clin North Am (1971) 0.90
Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. J Anal Toxicol (1997) 0.90
Structural features of IgA molecules which contribute to IgA nephropathy. J Nephrol (1999) 0.90
Familial congenital absence of adrenal glands; evaluation of glucocorticoid, mineralocorticoid, and estrogen metabolism in the perinatal period. J Pediatr (1974) 0.89
63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces. J Chromatogr (1985) 0.89
Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol (1995) 0.89
Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am J Kidney Dis (1999) 0.89
Twin delivery: influence of the presentation and method of delivery on the second twin. Am J Obstet Gynecol (1991) 0.89
Preterm birth at 23 to 26 weeks' gestation: is active obstetric management justified? Am J Obstet Gynecol (1987) 0.89
Gestational age- and birthweight-specific declines in infant mortality in Canada, 1985-94. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. Paediatr Perinat Epidemiol (2000) 0.89